Who owns BICYCLE THERAPEUTICS PLC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BCYC from SEC Form 13F filings across 103 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 103 institutions disclosed 37.3M shares of BICYCLE THERAPEUTICS PLC worth $158.0M — about 53.4% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
103
13F holders
$158.0M
value, 2026 filers
53.4%
of shares outstanding (37.3M sh)
18
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BCYC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 10.9M | $46.2M | 0.2% | 15.6% | 0.0% |
| 2 | FCPM III SERVICES B.V. | 3.5M | $14.7M | 2.0% | 5% | 0.0% |
| 3 | ARMISTICE CAPITAL, LLC | 3.4M | $14.4M | 0.2% | 4.9% | 0.0% |
| 4 | Long Focus Capital Management, LLC | 3.3M | $14.0M | 0.4% | 4.7% | 0.0% |
| 5 | ACADIAN ASSET MANAGEMENT LLC | 2.0M | $8.3M | 0.0% | 2.8% | 0.0% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 1.5M | $6.5M | 0.0% | 2.2% | +56.6% |
| 7 | GSK plc | 1.5M | $6.5M | 1.1% | 2.2% | 0.0% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 902,150 | $3.8M | 0.0% | 1.3% | -12.3% |
| 9 | MARSHALL WACE, LLP | 797,940 | $3.4M | 0.0% | 1.1% | +111.5% |
| 10 | Qube Research & Technologies Ltd | 775,567 | $3.3M | 0.0% | 1.1% | +151.3% |
| 11 | MORGAN STANLEY | 667,269 | $2.8M | 0.0% | 1% | +7.9% |
| 12 | SCHRODER INVESTMENT MANAGEMENT GROUP | 615,833 | $2.6M | 0.0% | 0.9% | 0.0% |
| 13 | CITADEL ADVISORS LLC | 554,225 | $2.3M | 0.0% | 0.8% | +47.0% |
| 14 | MILLENNIUM MANAGEMENT LLC | 553,967 | $2.3M | 0.0% | 0.8% | +95.1% |
| 15 | Peapod Lane Capital LLC | 537,978 | $2.3M | 1.5% | 0.8% | +344.2% |
| 16 | DIADEMA PARTNERS LP | 462,724 | $2.0M | 0.2% | 0.7% | -2.9% |
| 17 | TWO SIGMA INVESTMENTS, LP | 434,577 | $1.8M | 0.0% | 0.6% | +163.7% |
| 18 | JANE STREET GROUP, LLC | 392,163 | $1.7M | 0.0% | 0.6% | +79.8% |
| 19 | Birchview Capital, LP | 313,616 | $1.3M | 0.6% | 0.4% | -32.4% |
| 20 | BlackRock, Inc. | 280,386 | $1.2M | 0.0% | 0.4% | +0.5% |
| 21 | MOORE CAPITAL MANAGEMENT, LP | 275,000 | $1.2M | 0.0% | 0.4% | 0.0% |
| 22 | Rangeley Capital, LLC | 253,500 | $1.1M | 1.0% | 0.4% | +9.1% |
| 23 | Palo Alto Investors LP | 201,890 | $856,014 | 0.1% | 0.3% | 0.0% |
| 24 | Sculptor Capital LPNEW | 197,904 | $839,113 | 0.0% | 0.3% | new |
| 25 | FLAX POND CAPITAL, LLC | 196,136 | $910,071 | 0.7% | 0.3% | +11.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.